Noteworthy - Pharmaceutical Executive

ADVERTISEMENT

Noteworthy

European Biotech Struggles to Thrive

May 6, 2013

While not as bleak as believed, the outlook of European biotech sector is struggling compared with its US counterpart.

The New Commercial Model Myth

May 1, 2013

Pharma professionals need to find new competitive—not commercial—models to succeed in the competitive stage of the industry's lifecycle, writes Stan Bernard.

The Big Squeeze

May 1, 2013

New approaches to managing reimbursements for pharmacy benefit programs are testing Big Pharma.

Generic Drug Gains and Grumbles

May 1, 2013

Legal battles and regulatory missteps undermine access to low-cost generics, at home and abroad, writes Jill Wechsler.

Obamacare Will Boost Private Managed Care

May 1, 2013

Public access expansion under the ACA isn't really a "government takeover."

The 2013 Pharm Exec Top 50

May 1, 2013

Patent expiries dampen revenues for some of the biggest Big Pharma, but growth continues unabated for a few nimble "stealth" players moving steadily up the list.

2013 Dealmakers Outlook

April 1, 2013

Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.

Woman of the Year 2013

April 1, 2013

This year's HBA Woman of the Year is Merck's Bridgette Heller of Merck Consumer Care.

On-Market Pricing Strategies

April 1, 2013

List pricing strategies that diverge from these approaches without "hitting the cliff".

ADVERTISEMENT

Click here